Target intelligence / Profile preview

Keratin filament (Stratum corneum) (KRT)

Target
KRT
Molecular classification
Intermediate filament, Structural protein, Other
01

Overview

Keratin filaments in the stratum corneum are the primary structural components of the skin's outermost layer, providing a tough, insoluble barrier against environmental insults and water loss (StatPearls, NBK560714). These intermediate filaments, primarily composed of Keratin 1 and Keratin 10 in the suprabasal layers, undergo extensive cross-linking with proteins like loricrin and filaggrin to form the cornified envelope (UniProt, P04264). In various dermatological conditions such as psoriasis and ichthyosis, there is an overproduction or abnormal organization of these filaments, leading to hyperkeratosis and impaired barrier function (PubMed, 17503915). Therapeutic interventions often involve keratolytic agents like salicylic acid or urea, which soften and facilitate the shedding of the stratum corneum by disrupting the hydrogen bonds and protein structures within the keratin matrix. Additionally, retinoids modulate the expression of keratin genes to normalize skin cell turnover and differentiation. Understanding the dynamics of these filaments is crucial for developing treatments for skin disorders characterized by scaling and thickening of the epidermis.

Other names
CytokeratinTonofilamentKeratin 1Keratin 10Intermediate filamentCornified envelope keratin
02

Mechanism of action

Keratolytic agents act by disrupting the cohesive forces between keratinocytes and the structural integrity of keratin filaments through the breaking of hydrogen bonds and protein denaturation, thereby promoting desquamation. Retinoids and vitamin D analogs modulate the expression of keratin genes (e.g., KRT1 and KRT10) to normalize epidermal differentiation and reduce hyperkeratosis.

03

Biological functions

Barrier functionStructural integrityMechanical protectionHydration regulationOther
04

Disease associations

PsoriasisIchthyosisHyperkeratosisAtopic dermatitisOther
05

Safety considerations

Skin irritationErythemaImpaired barrier functionIncreased photosensitivityPotential for systemic toxicity (e.g., salicylism) with extensive application
06

Interacting drugs

Salicylic acid

6 more in the full profile.

07

Biomarkers

Keratin 1 (KRT1) expressionKeratin 10 (KRT10) expressionTransepidermal water loss (TEWL)Stratum corneum thickness

Beyond the preview

Go deeper on Keratin filament (Stratum corneum) (KRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin filament (Stratum corneum) (KRT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call